[go: up one dir, main page]

PE20020102A1 - Composicion topica oral que comprende un agente modulador de la respuesta del huesped frente a patogenos periodontales - Google Patents

Composicion topica oral que comprende un agente modulador de la respuesta del huesped frente a patogenos periodontales

Info

Publication number
PE20020102A1
PE20020102A1 PE2001000646A PE2001000646A PE20020102A1 PE 20020102 A1 PE20020102 A1 PE 20020102A1 PE 2001000646 A PE2001000646 A PE 2001000646A PE 2001000646 A PE2001000646 A PE 2001000646A PE 20020102 A1 PE20020102 A1 PE 20020102A1
Authority
PE
Peru
Prior art keywords
agents
host
oral
present
oral cavity
Prior art date
Application number
PE2001000646A
Other languages
English (en)
Inventor
Matthew Joseph Doyle
Stephen Joseph Hunter-Rinderle
Robert Ernest Singer
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24432968&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20020102(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE20020102A1 publication Critical patent/PE20020102A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Finger-Pressure Massage (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

SE REFIERE A UNA COMPOSICION TOPICA ORAL QUE COMPRENDE: a) UNA CANTIDAD DE UN AGENTE MODULADOR DE LA RESPUESTA AL HUESPED COMO: i) UN ANTAGONISTA H2 TAL COMO CIMETIDINA, ETINTIDINA, RANITIDINA, ROXATIDINA, ENTRE OTROS, ii) UN AGENTE ANTIINFLAMATORIO TAL COMO ASPIRINA, KETOROLACO, IBUPROFENO, NAPROXENO, ENTRE OTROS, iii) UN MODIFICADOR DEL ESTADO REDOX TAL COMO VITAMINA C, VITAMINA E, ENTRE OTROS, iv) INHIBIDOR DE METALOPROTEINASA, v) UN AGENTE ANTIOXIDANTE, ENTRE OTROS; Y b) UN AGENTE PORTADOR ORAL FARMACEUTICAMENTE ACEPTABLE. LA COMPOSICION PUEDE SER ADMINISTRADA JUNTO A UN AGENTE ANTIMICROBIANO, ANTIBIOTICO, ANALGESICO, DESENSIBILIZADORES DE LA DENTINA Y ES CLAVE PARA EL MANTENIMIENTO DE UN EQUILIBRIO DE LA RESPUESTA DEL HUESPED FRENTE A PATOGENOS PERIODONTALES EN LA CAVIDAD BUCAL ASI COMO TOXINAS Y ENDOTOXINAS LIBERADAS POR ESTOS GENTES PATOGENOS Y LA CITOQUINAS Y MEDIADORES INFLAMATORIOS INDUCIDOS POR ESTOS AGENTES PATOGENOS BUCALES. LA COMPOSICION SE ENCUENTRA EN FORMA ENJUAGUE BUCAL, PASTA DENTRIFICA, AEROSOL BUCAL, PASTILLA
PE2001000646A 2000-06-30 2001-06-28 Composicion topica oral que comprende un agente modulador de la respuesta del huesped frente a patogenos periodontales PE20020102A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60760200A 2000-06-30 2000-06-30

Publications (1)

Publication Number Publication Date
PE20020102A1 true PE20020102A1 (es) 2002-03-06

Family

ID=24432968

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000646A PE20020102A1 (es) 2000-06-30 2001-06-28 Composicion topica oral que comprende un agente modulador de la respuesta del huesped frente a patogenos periodontales

Country Status (12)

Country Link
US (1) US8277782B2 (es)
EP (1) EP1294367B1 (es)
JP (1) JP4754155B2 (es)
CN (1) CN1536989A (es)
AT (1) ATE401065T1 (es)
AU (1) AU2001271544A1 (es)
CA (1) CA2415065C (es)
DE (1) DE60134854D1 (es)
ES (1) ES2309076T3 (es)
MX (1) MXPA03000043A (es)
PE (1) PE20020102A1 (es)
WO (1) WO2002002096A2 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8283135B2 (en) * 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
US20040101494A1 (en) 2002-11-26 2004-05-27 Scott Douglas Craig Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth
KR20060121866A (ko) 2003-09-09 2006-11-29 디에스엠 아이피 어셋츠 비.브이. 산화에 민감한 물질 하나 이상을 함유하는 경구 활성을갖는 본질적으로 무수성의 국소 작용제
WO2005046363A2 (en) 2003-11-07 2005-05-26 U.S. Smokeless Tobacco Company Tobacco compositions
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
WO2005117849A1 (en) 2004-05-28 2005-12-15 Unigen Pharmaceuticals, Inc. Diarylalkanes as potent inhibitors of binuclear enzymes
US8168161B2 (en) * 2004-12-22 2012-05-01 Hill's Pet Nutrition, Inc. Method to promote oral health in companion animals
JP2006182662A (ja) * 2004-12-27 2006-07-13 Lion Corp 歯磨剤組成物
US20080045575A1 (en) * 2004-12-29 2008-02-21 Van Dyke Thomas E Delivery of H2 Antagonists
RU2381769C2 (ru) 2005-11-04 2010-02-20 Дзе Проктер Энд Гэмбл Компани Электрическое устройство для ухода за полостью рта
US20070140990A1 (en) * 2005-12-21 2007-06-21 Nataly Fetissova Oral Compositions Comprising Propolis
CA2660894C (en) 2006-07-20 2018-12-04 Izun Pharmaceuticals Corporation Film-delivering rinse
US8858995B2 (en) 2008-03-10 2014-10-14 University Of Louisville Research Foundation, Inc. Methods and compositions for controlled delivery of phytochemical agents
AU2009223653B2 (en) * 2008-03-10 2014-07-31 University Of Louisville Research Foundation, Inc. Methods and compositions for controlled delivery of phytochemical agents
KR101849695B1 (ko) 2008-07-21 2018-04-17 유니젠, 인크. 일련의 피부-화이트닝(라이트닝) 화합물
WO2011106089A1 (en) * 2010-02-24 2011-09-01 Bisco, Inc. Benzalkonium chloride compositions for inhibiting the hydrolytic activity of endogenous matrix metalloproteinases in dental restorations
CN109896935A (zh) 2011-03-24 2019-06-18 尤尼根公司 用于制备二芳基丙烷的化合物和方法
US8731747B2 (en) 2011-04-28 2014-05-20 General Electric Company Communication systems and method for a rail vehicle or other powered system
US8798807B2 (en) 2011-06-13 2014-08-05 General Electric Company Data distribution system and method for distributing data in a vehicle
US8510026B2 (en) 2011-06-13 2013-08-13 General Electric Company Data conversion system and method for converting data that is distributed in a vehicle
US8620552B2 (en) 2011-06-13 2013-12-31 General Electric Company Data communication system and method for communicating data in a vehicle
WO2013049507A1 (en) 2011-09-30 2013-04-04 Perio Sciences, Llc Antioxidant compositions for treatment of inflammation or oxidative damage
US20130274650A1 (en) * 2012-04-17 2013-10-17 Luitpold Pharmaceuticals, Inc. Stabilized ketorolac compositions
US20150210964A1 (en) 2014-01-24 2015-07-30 The Procter & Gamble Company Consumer Product Compositions
CN110024726B (zh) * 2019-04-03 2022-03-08 中国水产科学研究院长江水产研究所 天然产物在激活斑点叉尾鮰核受体ahr1和ahr2活性中的应用
CA3136620C (en) * 2019-04-10 2023-12-05 Black Tulip Management, Inc. Oral rinse compositions for reducing pathogens underlying tooth decay, periodontitis and oral malodor
JP2022526682A (ja) * 2019-04-10 2022-05-25 ブラック チューリップ マネージメント、インコーポレイテッド イヌにおける歯周病及び口臭の基礎をなす病原菌を低減し、歯周病及び口臭を治療するための口すすぎ用組成物
CN112494483B (zh) * 2020-11-13 2022-09-02 兰州大学 一种二硫杂环戊烯硫酮类化合物在抗菌方面的用途
CN115024355B (zh) * 2022-06-09 2023-06-09 宁波大学科学技术学院 对冷鲜肉保鲜的基于大蒜素的复合载体涂层的制备方法

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599228A (en) * 1981-01-19 1986-07-08 Vipont Laboratories, Inc. Antimicrobial agent
US5531982A (en) * 1987-01-30 1996-07-02 Colgate Palmolive Company Antimicrobial oral composition
US5204089A (en) * 1989-08-30 1993-04-20 Mitsui Norin Co., Ltd. Method of preventing the formation or aggrevation of dental plaque and method for reducing cariogenesis
US5198220A (en) 1989-11-17 1993-03-30 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5464609A (en) * 1990-03-16 1995-11-07 The Procter & Gamble Company Use of ketorolac for treatment of oral diseases and conditions
DE69111652T2 (de) * 1990-03-30 1996-05-02 Suntory Ltd Glukosyltransferase-Inhibitoren sowie Verfahren zur Vorbeugung von Karies und anti-karöse Nahrungsmittel mittels dieser Inhibitoren.
JPH0489428A (ja) 1990-07-30 1992-03-23 Kao Corp 多形核白血球活性化剤
US5147632A (en) * 1990-10-31 1992-09-15 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and chelating agent
US5356615A (en) * 1991-01-30 1994-10-18 Colgate Palmolive Company Antiplaque oral compositions
GB9110721D0 (en) * 1991-05-17 1991-07-10 Unilever Plc Dentifrice compositions
DE69220679T2 (de) * 1992-01-23 1997-10-23 Morinaga Milk Industry Co. Ltd., Tokio/Tokyo Antibakterielles mittel und behandlung von gegenständen mit diesem
CN1075868A (zh) 1992-03-02 1993-09-08 池洁 一种保健牙签
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
US5431927A (en) * 1992-06-16 1995-07-11 Colgate-Palmolive Company Pet food product having oral care properties
US5830511A (en) * 1992-06-25 1998-11-03 Bioxy Inc. Therapeutic, production and immunostimulatory uses of biocidal compositions
US6004587A (en) * 1992-06-25 1999-12-21 Bioxy Inc. Therapeutic, production and immunostimulatory uses of biocidal compositions
JP3333584B2 (ja) * 1993-04-19 2002-10-15 三井農林株式会社 歯質の耐酸性強化組成物
JP3464807B2 (ja) 1993-04-27 2003-11-10 サンスター株式会社 歯磨用組成物
US5451401A (en) * 1993-09-29 1995-09-19 The Procter & Gamble Company Diphosphonic acid esters as tartar control agents
CN1103776A (zh) 1993-12-17 1995-06-21 王殿安 降压防栓保健药物牙膏
GB2290233B (en) 1994-05-21 1998-06-17 Medical Express Tooth-whitening compositions containing both chlorite and chlorate salts
CN1109742A (zh) 1994-09-22 1995-10-11 许我先 心、脑血管保健牙膏
US5578293A (en) * 1994-12-06 1996-11-26 Colgate Palmolive Company Oral compositions containing stabilized stannous compounds having antiplaque and antitartar efficacy
US5639746A (en) * 1994-12-29 1997-06-17 The Procter & Gamble Company Hydroxamic acid-containing inhibitors of matrix metalloproteases
US5626838A (en) * 1995-03-13 1997-05-06 The Procter & Gamble Company Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
US5672598A (en) * 1995-03-21 1997-09-30 The Procter & Gamble Company Lactam-containing hydroxamic acids
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US6025326A (en) * 1995-07-07 2000-02-15 Intrabiotics Pharmaceuticals, Inc. Compositions and methods for the prevention and treatment of oral mucositis
AU7468096A (en) 1995-10-30 1997-05-22 Warner-Lambert Company Enhanced anti-inflammatory oral composition containing h2 receptor antagonist and antimicrobial oils
DE69719834T2 (de) * 1996-04-24 2003-11-20 Pfizer Inc., New York Dentalwerkstoffe enthaltend Cyclodextrine und phenolische Verbindungen
BR9709792A (pt) * 1996-06-12 1999-08-10 Procter & Gamble Utilização de antagonistas h2 para a fabricação de uma composição tópica para o tratamento de resfriados
US5753217A (en) * 1996-08-14 1998-05-19 William C. Christopfel Method of reducing oral malodor
US5766622A (en) * 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
RU2170232C2 (ru) * 1996-08-28 2001-07-10 Дзе Проктер Энд Гэмбл Компани Амиды фосфиновых кислот и способ предупреждения или лечения заболевания, связанного с нежелательной активностью металлопротеазы
NZ334256A (en) 1996-08-28 2000-11-24 Procter & Gamble 1-substituted sulphonyl-pyrrolidine derivatives useful as metalloprotease inhibitors
TR199900382T2 (xx) 1996-08-28 1999-05-21 The Procter & Gamble Company Heterosiklik metaloproteaz inhibit�rleri.
BR9712792A (pt) 1996-08-28 1999-12-14 Procter & Gamble Inibidores de metaloprotease bidentada.
TR199900400T2 (xx) 1996-08-28 1999-05-21 The Procter & Gamble Company Heterosiklik metaloproteaz inhibit�rleri.
AU727820B2 (en) 1996-08-28 2000-12-21 Procter & Gamble Company, The 1,3-diheterocyclic metalloprotease inhibitors
ATE272062T1 (de) * 1996-08-28 2004-08-15 Procter & Gamble Spirocyclisch metalloprotease inhibitoren
CN1233956A (zh) 1996-10-22 1999-11-03 普罗克特和甘保尔公司 含有柠檬酸锌盐的经口组合物
KR20000052736A (ko) 1996-10-22 2000-08-25 데이비드 엠 모이어 제1주석 글루코네이트를 함유하는 구강용 조성물
NZ335780A (en) 1996-10-23 2001-01-26 Univ New York State Res Found Compositions to control oral microbial oxidation-reduction (Eh) levels and treat gingivitis-periodontitis
US5906811A (en) * 1997-06-27 1999-05-25 Thione International, Inc. Intra-oral antioxidant preparations
EP1009737A2 (en) 1997-07-31 2000-06-21 The Procter & Gamble Company Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
US5875799A (en) * 1997-09-23 1999-03-02 Advanced Medical Instruments, Inc. Therapeutic dental floss for treating systemic diseases
US5875798A (en) * 1997-09-23 1999-03-02 Advanced Medical Instruments, Inc. Therapeutic toothpick for treating oral and systemic diseases
CN1213534A (zh) 1997-10-06 1999-04-14 陈创 口体舒治疗保健系统牙膏
JPH11139947A (ja) 1997-11-11 1999-05-25 Sunstar Inc マトリックスメタロプロテアーゼ阻害剤含有口腔用組成物
US6228347B1 (en) * 1997-12-01 2001-05-08 Thione International, Inc. Antioxidant gel for gingival conditions
US6350438B1 (en) * 1998-02-27 2002-02-26 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
US6132702A (en) * 1998-02-27 2000-10-17 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
JP3763075B2 (ja) * 1998-04-24 2006-04-05 サンスター株式会社 歯周病の予防又は治療用の食品組成物、口腔用組成物及び医薬組成物
WO2007079331A2 (en) * 2005-12-13 2007-07-12 Richard Paul Bonfiglio Antibacterial oral rinse formulation for preventing coronary artery disease

Also Published As

Publication number Publication date
AU2001271544A1 (en) 2002-01-14
WO2002002096A3 (en) 2002-09-12
CN1536989A (zh) 2004-10-13
WO2002002096A2 (en) 2002-01-10
DE60134854D1 (de) 2008-08-28
ATE401065T1 (de) 2008-08-15
CA2415065A1 (en) 2002-01-10
CA2415065C (en) 2009-09-15
JP4754155B2 (ja) 2011-08-24
ES2309076T3 (es) 2008-12-16
EP1294367B1 (en) 2008-07-16
JP2004501966A (ja) 2004-01-22
MXPA03000043A (es) 2003-10-15
EP1294367A2 (en) 2003-03-26
US20060193790A1 (en) 2006-08-31
US8277782B2 (en) 2012-10-02
WO2002002096A8 (en) 2003-11-06

Similar Documents

Publication Publication Date Title
PE20020102A1 (es) Composicion topica oral que comprende un agente modulador de la respuesta del huesped frente a patogenos periodontales
PT1294383E (pt) Composições orais compreendendo agentes antimicrobianos
DE50211204D1 (de) Cannabis extrakten pharmazeutische zusammensetzung
BRPI0414800A (pt) composições de higiene oral baseadas em morinda citrifolia e seus usos
Decker et al. Antimicrobial efficiency of mouthrinses versus and in combination with different photodynamic therapies on periodontal pathogens in an experimental study
BR9807199A (pt) Composição oral e processo para o tratamento e a prevenção de acúmulo de placa bacteriana sobre dentes.
BR0113751A (pt) Composições cosméticas e farmacêuticas e seus empregos
ATE473749T1 (de) Verwendung von rhamnolipiden zur wundheilung, behandlung und vorbeugung einer zahnfleischerkrankung und periodontaler regeneration
BR0209327A (pt) Composição para tratamento de constipação induzida por drogas
HRP20040480B1 (hr) Niska koncentracija peroksida za tretman i prevenciju vaginalnih infekcija
ES2150404T1 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
DE60020556D1 (de) Ionenkanal modulierende mittel
DOP2001000259A (es) Sistema de surfactantes para aumentar la captación de agente antibacteriano al tejido dental
Shetty et al. Highlights on role of antibiotics in periodontics
CN1069516C (zh) 一种槟榔药物牙膏组合物
ATE301469T1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
MXPA04011560A (es) Formulacion anti-cancer.
KR100417259B1 (ko) 트리암씨놀론 아세토나이드를 함유한 치은염, 구내염,치주염의 예방 및 치료용 구강 조성물
YU75002A (sh) Lokalna antioksidantna vitaminska smeša za negu kože
CO2024001131A2 (es) Composición farmacéutica oral para prevenir y/o tratar enfermedades de los tejidos blandos y duros que rodean al diente en la cavidad bucal
AR005136A1 (es) Compuestos antibioticos oligosacaridos hidrosolubles, una composicion farmaceutica que los contienen y el uso de los mismos para la preparacion de un medicamento
Karthikeyan et al. Non-Antibacterial Implications of Tetracyclines in the Management of Periodontitis: An Update. J Immunodefic Disor 2: 1
Properties Biological Therapies in Dentistry
TH48587A (th) สารผสมบำรุงรักษาผิวหนัง ซึ่งมีสารแสดงฤทธิ์บำรุงรักษาผิวหนังรวมกัน
BR9906150A (pt) Composição cosmética aquosa para limpeza e tratamento dos cabelos

Legal Events

Date Code Title Description
FD Application declared void or lapsed